Transaction with Affiliate Company
Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) on April 30, 2024
announced that its Board of Directors has authorized following related-party transaction
with an affiliated company.
Trademark License Agreement
- Grant trademark license to Samsung Biologics
□ Major Transaction Terms
| Transaction Item | License fee for use of trademark |
| Transaction Date | May 10, 2024 |
| Transaction Period | February 1, 2024-January 31, 2027 |
| Transaction Value | KRW 28,244 million (total transaction value: KRW 28,244 million) |
| Other information | - The transaction date is the date on which the trademark license agreement with Samsung Biologics will be executed. - Transaction period is the term of the trademark license agreement. - The transaction value is an estimate and may change in accordance with Samsung Biologics revenue. * The license fee is set at 0.5% of Samsung Biologics' revenue (excluding revenue or purchases not related to the use of trademark) and shall be paid every year during the transaction period. |
Other Information:
ž Number of Independent Directors Present at the BOD Meeting: 6/6
ž Attendance of Audit Committee: Y
※ This disclosure is in accordance with the Korean Fair Trade Act, which mandates that a company must disclose
its financial and real estate transactions in the event the value of such a transaction is greater than or equal to
KRW 10 billion and the counterparty is a financial affiliate of the party required to make the disclosure.
Transaction with Affiliate Company
Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) on April 30, 2024
announced that its Board of Directors has authorized following related-party transaction
with an affiliated company.
Trademark License Agreement
- Grant trademark license to Samsung Bioepis
□ Major Transaction Terms
| Transaction Item | License fee for use of trademark |
| Transaction Date | May 10, 2024 |
| Transaction Period | February 1, 2024 - January 31, 2027 |
| Transaction Value | KRW 12,843 million (total transaction value: KRW 12,843 million) |
| Other information | - The transaction date is the date on which the trademark license agreement with Samsung Bioepis will be executed. - Transaction period is the term of the trademark license agreement. - The transaction value is an estimate and may change in accordance with Samsung Bioepis revenue. * The license fee is set at 0.5% of Samsung Bioepis' revenue (excluding revenue or purchases not related to the use of trademark) and shall be paid every year during the transaction period. |
Other Information:
ž Number of Independent Directors Present at the BOD Meeting: 6/6
ž Attendance of Audit Committee: Y
※ This disclosure is in accordance with the Korean Fair Trade Act, which mandates that a company must disclose
its financial and real estate transactions in the event the value of such a transaction is greater than or equal to
KRW 10 billion and the counterparty is a financial affiliate of the party required to make the disclosure.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.